top of page
About
Platform
Clinical Studies
Pipeline
News
Presentations & Publications
More
Use tab to navigate through the menu items.
Skyhawk Announces Collaboration Agreement with Sanofi for Oncology and Immunology Targets
Jul 6, 2022
2 min read
Bill Haney’s latest startup scores deal from Sanofi its newest Big Pharma partner, with $54M upfront
Jul 5, 2022
3 min read
Skyhawk Therapeutics Completes New Investment Round
Sep 14, 2021
1 min read
Bill Haney adds another $133M to Skyhawk’s coffers, as the RNA startup guns for the clinic
Sep 13, 2021
3 min read
Skyhawk Therapeutics Expands Leadership Team, Appointing Elliot Ehrich MD as President
Apr 12, 2021
2 min read
$40M up front: Skyhawk takes flight with Vertex deal
Dec 22, 2020
3 min read
A busy, buzzy Vertex finds a high-profile partner in the RNA-drugging world to launch a fresh ...
Dec 22, 2020
2 min read
Vertex joins Skyhawk’s roster of A-list partners, securing options on RNA splicing modulators
Dec 22, 2020
2 min read
The Endpoints 11 : Here are some of the most promising startups in biotech. And Covid-19 isn’t ...
Sep 29, 2020
2 min read
Skyhawk Therapeutics boosts Merck collab pact with added targets, upfront and biobucks
May 11, 2020
2 min read
Skyhawk Therapeutics Announces Expansion of its Collaboration Agreement with Merck
May 11, 2020
2 min read
Merck doubles down on Skyhawk’s tech to drug RNA, promising $600M per autoimmune, metabolic target
May 11, 2020
2 min read
The 20 under 40 : Inside the next generation of biopharma leaders
Apr 5, 2020
5 min read
Experienced Business Leader in Biopharmaceutical Industry Joins as Chief Operating Officer
Feb 24, 2020
2 min read
The 20 Startups to Watch in Boston in 2020
Dec 16, 2019
1 min read
Celgene execs shell out $92M cash for a pair of R&D deals that will fit perfectly in their new home
Nov 12, 2019
2 min read
Skyhawk’s $80M Celgene deal expands remit to autoimmune
Nov 12, 2019
1 min read
C&EN’s 2019 10 Start-Ups to Watch
Nov 11, 2019
4 min read
Skyhawk Therapeutics Announces a Second Multi-Target Collaboration Agreement with Celgene
Nov 9, 2019
2 min read
Fattening the bankroll, Bill Haney adds cancer R&D powerhouse Merck to Skyhawk’s roster
Jul 7, 2019
2 min read
bottom of page